Skip to content
Home
About us
Insights
Stocks
Compliance
Special Services
Contact
Language
EN
BR
EN
EN
BR
Tag:
HAPV3
Insights
Hapvida Says Review of 947,000 Members Aims to Rebalance Contracts After ANS Injunction
August 20, 2026
Insights
Hapvida reviews contracts, cuts units and puts R$4 billion in annual purchases under review to restore margins
August 13, 2026
Insights
Hapvida Revives NotreDame Brand in Push Into Premium Health Plans
July 27, 2026
Insights
Listed Healthcare Companies Create Nearly 80,000 Jobs, Expanding Headcount by 48% Since 2019
June 29, 2026
Insights
Hapvida Expands Research Center, Targets High-Complexity Therapies
June 25, 2026
Insights
After the Storm, Hapvida Eases Credit Stress
May 22, 2026
Insights
Hapvida cuts medical costs, but still owes investors a turnaround
May 11, 2026
Insights
Amil Leads March Beneficiary Gains as Bradsaúde Wins the Quarter
May 11, 2026
Insights
Hapvida controllers raise stake to shield board control
April 24, 2026
Insights
Hapvida treats asset sales as “a possibility” under investor pressure
April 6, 2026
1
2
Next Page
→
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
